Initiative seeks global accord on recognition and management of allergies, asthma and immune deficiencies, 2012
Another press release from AAAAI.org:
***
Initiative seeks global accord on recognition and management of allergies, asthma and immune deficiencies
iCAALL will release international consensus reports to positively impact care, cost-containmentand policy decisions.
ORLANDO—Hundreds of millions of people in the world suffer from allergies, and it is estimated that 300 million have asthma. Inadequate or improper diagnosis and treatment of these chronic diseases and of immunodeficiency disorders results in lost productivity and substantial medical and socioeconomic burdens throughout the world.
Recognizing a lack of consensus-driven information and general recommendations, four of the most influential allergy/immunology professional organizations have joined forces to launch the International Collaboration in Asthma, Allergy and Immunology (iCAALL). The effort was announced during the 2012 Annual Meeting of the American Academy of Allergy, Asthma & Immunology in Orlando, FL.
Participating in iCAALL are the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma & Immunology (ACAAI), the European Academy of Allergy and Clinical Immunology (EAACI) and the World Allergy Organization (WAO).
“iCAALL is designed to collect and disseminate consensus-driven information about allergies, asthma and immunological diseases,” according to iCAALL’s Chair, Dennis Ledford, MD, FAAAAI. “We are confident that communicating this knowledge can positively impact diagnosis and treatment, as well as cost-containment and policy decisions.”
A major focus of this new initiative is the production of a series of International Consensus (ICON) reports. These documents will offer general recommendations based on global challenges in caring for patients with allergic and immunologic diseases. The first ICON on food allergy is set to be published in The Journal of Allergy and Clinical Immunology (JACI) and is available at http://www.jacionline.org/article/S0091-6749%2812%2900254-0/fulltext.
***
Initiative seeks global accord on recognition and management of allergies, asthma and immune deficiencies
iCAALL will release international consensus reports to positively impact care, cost-containmentand policy decisions.
ORLANDO—Hundreds of millions of people in the world suffer from allergies, and it is estimated that 300 million have asthma. Inadequate or improper diagnosis and treatment of these chronic diseases and of immunodeficiency disorders results in lost productivity and substantial medical and socioeconomic burdens throughout the world.
Recognizing a lack of consensus-driven information and general recommendations, four of the most influential allergy/immunology professional organizations have joined forces to launch the International Collaboration in Asthma, Allergy and Immunology (iCAALL). The effort was announced during the 2012 Annual Meeting of the American Academy of Allergy, Asthma & Immunology in Orlando, FL.
Participating in iCAALL are the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma & Immunology (ACAAI), the European Academy of Allergy and Clinical Immunology (EAACI) and the World Allergy Organization (WAO).
“iCAALL is designed to collect and disseminate consensus-driven information about allergies, asthma and immunological diseases,” according to iCAALL’s Chair, Dennis Ledford, MD, FAAAAI. “We are confident that communicating this knowledge can positively impact diagnosis and treatment, as well as cost-containment and policy decisions.”
A major focus of this new initiative is the production of a series of International Consensus (ICON) reports. These documents will offer general recommendations based on global challenges in caring for patients with allergic and immunologic diseases. The first ICON on food allergy is set to be published in The Journal of Allergy and Clinical Immunology (JACI) and is available at http://www.jacionline.org/article/S0091-6749%2812%2900254-0/fulltext.
Comments